Doriana Fruci

14PUBLICATIONS
34CO-AUTHORS
Innate immunityTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 02, 2026
Transforming growth factor β induced as a novel secreted immune checkpoint counterinhibiting human tumor-associated T cells.

Maria Manuela Rosado, Eleonora Timperi, Ombretta Melaiu

|Nov 11, 2025
Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma.

Ombretta Melaiu, Marco Chierici, Paula Gragera

|Feb 26, 2025
Immunogenic Cell Death Inducers in Cancer Immunotherapy to Turn Cold Tumors into Hot Tumors.

Valeria Lucarini, Ombretta Melaiu, Paula Gragera

|Oct 23, 2024
Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma.

Patrizia Tempora, Silvia D'Amico, Paula Gragera

|Nov 18, 2022
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma.

Valeria Lucarini, Ombretta Melaiu, Silvia D'Amico

Pageof 3